| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHS2000025 | 依非韦伦拉米夫定替诺福韦片 | efavirenz;lamivudine;Tenofovir disoproxil fumarate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-03-18 | 美信美达医药信息咨询（北京）有限责任公司 | Meixin Meida Medical Information Consulting (Beijing) Co Ltd;Mylan Pharmaceuticals Inc;Mylan Laboratories Ltd | In Review | 2020-03-17 | view |
| JYHS2300046 | 依非韦伦拉米夫定替诺福韦片 | efavirenz;lamivudine;Tenofovir disoproxil fumarate | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-04-01 | Laurus Labs Ltd;Biobetta Pharmaceuticals (Shanghai) Co Ltd | view | |||
| JXHS2200055 | 依非韦伦拉米夫定替诺福韦片 | efavirenz;lamivudine;Tenofovir disoproxil fumarate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2022-06-22 | Mylan Laboratories Ltd | view | |||
| CYHS2200146 | 依非韦伦拉米夫定替诺福韦片 | efavirenz;lamivudine;Tenofovir disoproxil fumarate | Tablet | Chemical Drugs(3) | Generic Drug | 2022-01-21 | Shanghai DESANO Biopharmaceutical Co Ltd | view |